BIOJECT MEDICAL TECHNOLOGIES INC 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 4, 2010

Insider Transaction Report

Form 4
Period: 2009-12-31
FARRELL CHRISTINE
VP of Finance
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2009-12-3124,000164,796 total
    From: 2009-12-31BJCT Common Stock (24,000 underlying)
  • Exercise/Conversion

    BJCT Common Stock

    2009-12-31+24,000225,443 total
Holdings
  • BJCT Common Stock

    (indirect: By 401(k))
    73,687
Footnotes (4)
  • [F1]Vesting of 10,000 Unconditional Restricted Stock Unit shares awarded 6/1/06, 3,500 Conditional Restricted Stock Unit shares awarded 12/7/06 and 10,500 Conditional Restricted Stock Unit shares awarded 6/14/07.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F3]No expiration date.
  • [F4]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 64,696 Restricted Stock Unit 89,000.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT